BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 18089838)

  • 1. Dioxin-mediated up-regulation of aryl hydrocarbon receptor target genes is dependent on the calcium/calmodulin/CaMKIalpha pathway.
    Monteiro P; Gilot D; Le Ferrec E; Rauch C; Lagadic-Gossmann D; Fardel O
    Mol Pharmacol; 2008 Mar; 73(3):769-77. PubMed ID: 18089838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the aryl hydrocarbon receptor by the calcium/calmodulin-dependent protein kinase kinase inhibitor 7-oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic acid (STO-609).
    Monteiro P; Gilot D; Langouet S; Fardel O
    Drug Metab Dispos; 2008 Dec; 36(12):2556-63. PubMed ID: 18755850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi-based screening identifies kinases interfering with dioxin-mediated up-regulation of CYP1A1 activity.
    Gilot D; Le Meur N; Giudicelli F; Le Vée M; Lagadic-Gossmann D; Théret N; Fardel O
    PLoS One; 2011 Mar; 6(3):e18261. PubMed ID: 21479225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of aryl hydrocarbon receptor in basal and 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced expression of target genes in primary human hepatocytes.
    Le Vee M; Jouan E; Fardel O
    Toxicol In Vitro; 2010 Sep; 24(6):1775-81. PubMed ID: 20619336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akti-1/2, an allosteric inhibitor of Akt 1 and 2, efficiently inhibits CaMKIα activity and aryl hydrocarbon receptor pathway.
    Gilot D; Giudicelli F; Lagadic-Gossmann D; Fardel O
    Chem Biol Interact; 2010 Dec; 188(3):546-52. PubMed ID: 20832391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on MCF-7, RL95-2, and LNCaP cells: role of target steroid hormones in cellular responsiveness to CYP1A1 induction.
    Jana NR; Sarkar S; Ishizuka M; Yonemoto J; Tohyama C; Sone H
    Mol Cell Biol Res Commun; 2000 Sep; 4(3):174-80. PubMed ID: 11281733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer.
    Ishida M; Mikami S; Kikuchi E; Kosaka T; Miyajima A; Nakagawa K; Mukai M; Okada Y; Oya M
    Carcinogenesis; 2010 Feb; 31(2):287-95. PubMed ID: 19755661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 12-O-tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells.
    Spink BC; Fasco MJ; Gierthy JF; Spink DC
    J Cell Biochem; 1998 Sep; 70(3):289-96. PubMed ID: 9706865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone accelerates degradation of aryl hydrocarbon receptor (AHR) and suppresses CYP1A1 induction in placental JEG-3 cell line.
    Stejskalova L; Rulcova A; Vrzal R; Dvorak Z; Pavek P
    Toxicol Lett; 2013 Nov; 223(2):183-91. PubMed ID: 24091107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.
    Matthews J; Wihlén B; Thomsen J; Gustafsson JA
    Mol Cell Biol; 2005 Jul; 25(13):5317-28. PubMed ID: 15964790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially.
    Ciolino HP; Daschner PJ; Yeh GC
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):715-22. PubMed ID: 10359656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aryl hydrocarbon receptor (AHR) regulation of L-Type Amino Acid Transporter 1 (LAT-1) expression in MCF-7 and MDA-MB-231 breast cancer cells.
    Tomblin JK; Arthur S; Primerano DA; Chaudhry AR; Fan J; Denvir J; Salisbury TB
    Biochem Pharmacol; 2016 Apr; 106():94-103. PubMed ID: 26944194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
    Wihlén B; Ahmed S; Inzunza J; Matthews J
    Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl-hydrocarbon receptor-dependent pathway and toxic effects of TCDD in humans: a population-based study in Seveso, Italy.
    Baccarelli A; Pesatori AC; Masten SA; Patterson DG; Needham LL; Mocarelli P; Caporaso NE; Consonni D; Grassman JA; Bertazzi PA; Landi MT
    Toxicol Lett; 2004 Apr; 149(1-3):287-93. PubMed ID: 15093275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain mediates the dioxin-induced activation and down-regulation of the aryl hydrocarbon receptor.
    Dale YR; Eltom SE
    Mol Pharmacol; 2006 Nov; 70(5):1481-7. PubMed ID: 16891617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium/calmodulin signaling elicits release of cytochrome c during 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced apoptosis in the human lymphoblastic T-cell line, L-MAT.
    Kobayashi D; Ahmed S; Ishida M; Kasai S; Kikuchi H
    Toxicology; 2009 Apr; 258(1):25-32. PubMed ID: 19167453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9.
    Peng TL; Chen J; Mao W; Song X; Chen MH
    BMC Cell Biol; 2009 Apr; 10():27. PubMed ID: 19371443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke.
    Ishida M; Mikami S; Shinojima T; Kosaka T; Mizuno R; Kikuchi E; Miyajima A; Okada Y; Oya M
    Int J Cancer; 2015 Jul; 137(2):299-310. PubMed ID: 25523818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCDD-mediated alterations in the AhR-dependent pathway in Seveso, Italy, 20 years after the accident.
    Landi MT; Bertazzi PA; Baccarelli A; Consonni D; Masten S; Lucier G; Mocarelli P; Needham L; Caporaso N; Grassman J
    Carcinogenesis; 2003 Apr; 24(4):673-80. PubMed ID: 12727795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism-based polycyclic aromatic acetylene inhibition of CYP1B1 in 10T1/2 cells potentiates aryl hydrocarbon receptor activity.
    Alexander DL; Zhang L; Foroozesh M; Alworth WL; Jefcoate CR
    Toxicol Appl Pharmacol; 1999 Dec; 161(2):123-39. PubMed ID: 10581206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.